• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACW 0.00% 2.4¢

ACTINOGEN MEDICAL LIMITED - Announcements

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight arrow Created with Sketch.

Actinogen reveals XanaCIDD phase 2a trials

Announcements


ACW Application for quotation of securities - ACW13/08/24 download Created with Sketch. 17.95KB
ACW ACW XanaCIDD phase 2a trial topline resultsPRICE SENSITIVE12/08/24 download Created with Sketch. 1.1MB
ACW Trading HaltPRICE SENSITIVE08/08/24 download Created with Sketch. 664.71KB
ACW Application for quotation of securities - ACW31/07/24 download Created with Sketch. 20.4KB
ACW ACW CMO presents academic poster at AAIC in Philadelphia29/07/24 download Created with Sketch. 2.52MB
ACW Application for quotation of securities - ACW25/07/24 download Created with Sketch. 17.96KB
ACW Application for quotation of securities - ACW24/07/24 download Created with Sketch. 17.96KB
ACW ACW June 2024 quarterly activity report & Appendix 4CPRICE SENSITIVE22/07/24 download Created with Sketch. 590.63KB
ACW Application for quotation of securities - ACW19/07/24 download Created with Sketch. 17.96KB
ACW Application for quotation of securities - ACW18/07/24 download Created with Sketch. 17.96KB
ACW Application for quotation of securities - ACW17/07/24 download Created with Sketch. 17.96KB
ACW Application for quotation of securities - ACW10/07/24 download Created with Sketch. 20.42KB
ACW Results of Meeting09/07/24 download Created with Sketch. 235.34KB
ACW Application for quotation of securities - ACW05/07/24 download Created with Sketch. 15.52KB
ACW Application for quotation of securities - ACW04/07/24 download Created with Sketch. 20.42KB
ACW ACW XanaCIDD depression trial results expected early AugustPRICE SENSITIVE02/07/24 download Created with Sketch. 248.15KB
ACW Positive Xanamem biomarker trial published in Jnl Alz DisPRICE SENSITIVE26/06/24 download Created with Sketch. 317.48KB
ACW Application for quotation of securities - ACW17/06/24 download Created with Sketch. 17.14KB
ACW Letter to Shareholders, Notice of GM & Proxy Form07/06/24 download Created with Sketch. 513.49KB
ACW Appendix 3Ys x 507/06/24 download Created with Sketch. 496.43KB
ACW Notification regarding unquoted securities - ACW05/06/24 download Created with Sketch. 14.53KB
ACW Application for quotation of securities - ACW05/06/24 download Created with Sketch. 15.65KB
ACW ACW Oversubscribed $3.9 million entitlement offer completedPRICE SENSITIVE05/06/24 download Created with Sketch. 218.56KB
ACW ACW poster presentation at ADRF conference 202403/06/24 download Created with Sketch. 1.04MB
ACW Actinogen entitlement offer closed and oversubscribedPRICE SENSITIVE30/05/24 download Created with Sketch. 240.11KB
ACW ACW Clinical Trials Science Forum slides & registration23/05/24 download Created with Sketch. 1.88MB
ACW Change in substantial holding16/05/24 download Created with Sketch. 167.22KB
ACW ACWs $3.9m entitlement offer opens & letters distribute15/05/24 download Created with Sketch. 657.01KB
ACW Notification regarding unquoted securities - ACW14/05/24 download Created with Sketch. 17.66KB
ACW Cleansing Notice14/05/24 download Created with Sketch. 243.77KB
ACW Application for quotation of securities - ACW14/05/24 download Created with Sketch. 15.84KB
ACW ACW Clinical Trials Science Forum 23 May registration detail13/05/24 download Created with Sketch. 223.07KB
ACW Application for quotation of securities - ACW08/05/24 download Created with Sketch. 15.54KB
ACW ACW lodges Prospectus for entitlement offer of up to $3.9m07/05/24 download Created with Sketch. 261.29KB
ACW Prospectus - Non-renounceable Entitlement OfferPRICE SENSITIVE07/05/24 download Created with Sketch. 470.52KB
ACW Proposed issue of securities - ACW03/05/24 download Created with Sketch. 32.34KB
ACW Actinogen announces capital raising of up to $8.9 millionPRICE SENSITIVE03/05/24 download Created with Sketch. 2.68MB
ACW Trading HaltPRICE SENSITIVE01/05/24 download Created with Sketch. 333.62KB
ACW ACW March 2024 quarterly activity report & Appendix 4CPRICE SENSITIVE30/04/24 download Created with Sketch. 592.09KB
ACW ACW completes cognition & depression phase 2 trial enrolmentPRICE SENSITIVE22/04/24 download Created with Sketch. 244.8KB
ACW First patient treated in ACW XanaMIA ph 2b Alzheimers trialPRICE SENSITIVE15/04/24 download Created with Sketch. 238.21KB
ACW Notification of cessation of securities - ACW15/04/24 download Created with Sketch. 12.73KB
ACW Appendix 3Y-Mr Malcolm McComas05/04/24 download Created with Sketch. 193.86KB
ACW Notification of cessation of securities - ACW05/04/24 download Created with Sketch. 12.77KB
ACW Application for quotation of securities - ACW03/04/24 download Created with Sketch. 17.11KB
ACW ACW corporate presentation revised licensing slide25/03/24 download Created with Sketch. 356.48KB
ACW Notification of buy-back - ACW20/03/24 download Created with Sketch. 12.67KB
ACW Actinogen corporate presentation March 202420/03/24 download Created with Sketch. 3.22MB
ACW Application for quotation of securities - ACW07/03/24 download Created with Sketch. 15.49KB
ACW ACW XanaCIDD depression trial enters final enrolment phase07/03/24 download Created with Sketch. 241.33KB
ACW Actinogen CMO presents at ADPD 2024 conference06/03/24 download Created with Sketch. 474.43KB
ACW Actinogen HY2024 financial results two key phase 2 trialPRICE SENSITIVE26/02/24 download Created with Sketch. 256.58KB
ACW Actinogen HY2024 financial report and Appendix 4DPRICE SENSITIVE26/02/24 download Created with Sketch. 2.75MB
ACW Application for quotation of securities - ACW21/02/24 download Created with Sketch. 17.95KB
ACW Response to ASX Aware QueryPRICE SENSITIVE20/02/24 download Created with Sketch. 934.62KB
ACW Application for quotation of securities - ACW16/02/24 download Created with Sketch. 17.94KB
ACW Actinogen awarded UK Innovation Passport for XanamemPRICE SENSITIVE15/02/24 download Created with Sketch. 242.2KB
ACW Application for quotation of securities - ACW09/02/24 download Created with Sketch. 17.51KB
ACW Notification of cessation of securities - ACW01/02/24 download Created with Sketch. 21.59KB
ACW ACW December 2023 quarterly activity report & Appendix 4CPRICE SENSITIVE30/01/24 download Created with Sketch. 510KB
ACW Positive Xanamem brain PET study peer-reviewed publication24/01/24 download Created with Sketch. 274.99KB
ACW ACW CEO & CMO present at Sachs Neuroscience Innovation Forum08/01/24 download Created with Sketch. 1.97MB
ACW First site activated in ACW XanaMIA Phase 2b AD trial20/12/23 download Created with Sketch. 241.49KB
ACW Notification of cessation of securities - ACW13/12/23 download Created with Sketch. 21.6KB
ACW Appendix 3Ys x 501/12/23 download Created with Sketch. 284.49KB
ACW Application for quotation of securities - ACW01/12/23 download Created with Sketch. 30.38KB
ACW Appendix 3Y-Dr George Morstyn28/11/23 download Created with Sketch. 194.64KB
ACW Appendix 3Y-Dr Geoff Brooke28/11/23 download Created with Sketch. 194.89KB
ACW Notification of cessation of securities - ACW28/11/23 download Created with Sketch. 21.61KB
ACW Actinogen receives $4.8 million R&D tax incentive rebatePRICE SENSITIVE28/11/23 download Created with Sketch. 224.74KB
ACW ACW XanaCIDD trial enrolment exceeds 50 percent28/11/23 download Created with Sketch. 221.05KB
ACW Amended Constitution17/11/23 download Created with Sketch. 420.34KB
ACW Results of AGM17/11/23 download Created with Sketch. 237.83KB
ACW Actinogen 2023 AGM - Chairs address and CEOs presentation17/11/23 download Created with Sketch. 2.48MB
ACW ACW CEO presents at Bell Potter Healthcare Conference 202315/11/23 download Created with Sketch. 3.15MB
ACW Application for quotation of securities - ACW08/11/23 download Created with Sketch. 26.71KB
ACW Actinogen appoints William Souter as new CFO08/11/23 download Created with Sketch. 239.79KB
ACW Amendment to Actinogen 2023 AGM resolutions 6 to 1027/10/23 download Created with Sketch. 212.49KB
ACW ACW CMO presents academic poster at CTAD 2023 conference25/10/23 download Created with Sketch. 592.86KB
ACW ACW CEO presentation for meetings at BIO Investor Forum USA18/10/23 download Created with Sketch. 3.33MB
ACW Actinogen September quarterly activity report & Appendix 4CPRICE SENSITIVE16/10/23 download Created with Sketch. 511.35KB
ACW Annual Report to Shareholders13/10/23 download Created with Sketch. 4.19MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form13/10/23 download Created with Sketch. 714.25KB
ACW Notification of cessation of securities - ACW11/10/23 download Created with Sketch. 21.52KB
ACW ACW CEO presents to Dementia Trials Australia conference06/10/23 download Created with Sketch. 1.69MB
ACW ACW presents to the Asian Society Against Dementia congress29/09/23 download Created with Sketch. 1.54MB
ACW Change in substantial holding27/09/23 download Created with Sketch. 166.64KB
ACW Notification of buy-back - ACW27/09/23 download Created with Sketch. 21.78KB
ACW Date of AGM and Closing Date for Director Nominations27/09/23 download Created with Sketch. 174.05KB
ACW Actinogen enhances XanaMIA Phase 2b Alzheimers trialPRICE SENSITIVE26/09/23 download Created with Sketch. 219.7KB
ACW Change in substantial holding20/09/23 download Created with Sketch. 166.67KB
ACW Notification regarding unquoted securities - ACW15/09/23 download Created with Sketch. 27.49KB
ACW Application for quotation of securities - ACW15/09/23 download Created with Sketch. 24.81KB
ACW Appendix 3Y-Mr Malcolm McComas12/09/23 download Created with Sketch. 195.82KB
ACW Appendix 3Y-Dr George Morstyn12/09/23 download Created with Sketch. 195.15KB
ACW Appendix 3Y-Dr Steven Gourlay12/09/23 download Created with Sketch. 194.14KB
ACW Appendix 3Y-Dr Geoffrey Brooke12/09/23 download Created with Sketch. 241.05KB
ACW Notification regarding unquoted securities - ACW11/09/23 download Created with Sketch. 23.88KB
ACW Application for quotation of securities - ACW11/09/23 download Created with Sketch. 24.91KB
ACW Actinogen closes successful $10 million rights issue offerPRICE SENSITIVE07/09/23 download Created with Sketch. 218.02KB
ACW Application for quotation of securities - ACW
13/08/24 download Created with Sketch. 17.95KB
ACW ACW XanaCIDD phase 2a trial topline results
12/08/24PRICE SENSITIVE download Created with Sketch. 1.1MB
ACW Trading Halt
08/08/24PRICE SENSITIVE download Created with Sketch. 664.71KB
ACW Application for quotation of securities - ACW
31/07/24 download Created with Sketch. 20.4KB
ACW ACW CMO presents academic poster at AAIC in Philadelphia
29/07/24 download Created with Sketch. 2.52MB
ACW Application for quotation of securities - ACW
25/07/24 download Created with Sketch. 17.96KB
ACW Application for quotation of securities - ACW
24/07/24 download Created with Sketch. 17.96KB
ACW ACW June 2024 quarterly activity report & Appendix 4C
22/07/24PRICE SENSITIVE download Created with Sketch. 590.63KB
ACW Application for quotation of securities - ACW
19/07/24 download Created with Sketch. 17.96KB
ACW Application for quotation of securities - ACW
18/07/24 download Created with Sketch. 17.96KB
ACW Application for quotation of securities - ACW
17/07/24 download Created with Sketch. 17.96KB
ACW Application for quotation of securities - ACW
10/07/24 download Created with Sketch. 20.42KB
ACW Results of Meeting
09/07/24 download Created with Sketch. 235.34KB
ACW Application for quotation of securities - ACW
05/07/24 download Created with Sketch. 15.52KB
ACW Application for quotation of securities - ACW
04/07/24 download Created with Sketch. 20.42KB
ACW ACW XanaCIDD depression trial results expected early August
02/07/24PRICE SENSITIVE download Created with Sketch. 248.15KB
ACW Positive Xanamem biomarker trial published in Jnl Alz Dis
26/06/24PRICE SENSITIVE download Created with Sketch. 317.48KB
ACW Application for quotation of securities - ACW
17/06/24 download Created with Sketch. 17.14KB
ACW Letter to Shareholders, Notice of GM & Proxy Form
07/06/24 download Created with Sketch. 513.49KB
ACW Appendix 3Ys x 5
07/06/24 download Created with Sketch. 496.43KB
ACW Notification regarding unquoted securities - ACW
05/06/24 download Created with Sketch. 14.53KB
ACW Application for quotation of securities - ACW
05/06/24 download Created with Sketch. 15.65KB
ACW ACW Oversubscribed $3.9 million entitlement offer completed
05/06/24PRICE SENSITIVE download Created with Sketch. 218.56KB
ACW ACW poster presentation at ADRF conference 2024
03/06/24 download Created with Sketch. 1.04MB
ACW Actinogen entitlement offer closed and oversubscribed
30/05/24PRICE SENSITIVE download Created with Sketch. 240.11KB
ACW ACW Clinical Trials Science Forum slides & registration
23/05/24 download Created with Sketch. 1.88MB
ACW Change in substantial holding
16/05/24 download Created with Sketch. 167.22KB
ACW ACWs $3.9m entitlement offer opens & letters distribute
15/05/24 download Created with Sketch. 657.01KB
ACW Notification regarding unquoted securities - ACW
14/05/24 download Created with Sketch. 17.66KB
ACW Cleansing Notice
14/05/24 download Created with Sketch. 243.77KB
ACW Application for quotation of securities - ACW
14/05/24 download Created with Sketch. 15.84KB
ACW ACW Clinical Trials Science Forum 23 May registration detail
13/05/24 download Created with Sketch. 223.07KB
ACW Application for quotation of securities - ACW
08/05/24 download Created with Sketch. 15.54KB
ACW ACW lodges Prospectus for entitlement offer of up to $3.9m
07/05/24 download Created with Sketch. 261.29KB
ACW Prospectus - Non-renounceable Entitlement Offer
07/05/24PRICE SENSITIVE download Created with Sketch. 470.52KB
ACW Proposed issue of securities - ACW
03/05/24 download Created with Sketch. 32.34KB
ACW Actinogen announces capital raising of up to $8.9 million
03/05/24PRICE SENSITIVE download Created with Sketch. 2.68MB
ACW Trading Halt
01/05/24PRICE SENSITIVE download Created with Sketch. 333.62KB
ACW ACW March 2024 quarterly activity report & Appendix 4C
30/04/24PRICE SENSITIVE download Created with Sketch. 592.09KB
ACW ACW completes cognition & depression phase 2 trial enrolment
22/04/24PRICE SENSITIVE download Created with Sketch. 244.8KB
ACW First patient treated in ACW XanaMIA ph 2b Alzheimers trial
15/04/24PRICE SENSITIVE download Created with Sketch. 238.21KB
ACW Notification of cessation of securities - ACW
15/04/24 download Created with Sketch. 12.73KB
ACW Appendix 3Y-Mr Malcolm McComas
05/04/24 download Created with Sketch. 193.86KB
ACW Notification of cessation of securities - ACW
05/04/24 download Created with Sketch. 12.77KB
ACW Application for quotation of securities - ACW
03/04/24 download Created with Sketch. 17.11KB
ACW ACW corporate presentation revised licensing slide
25/03/24 download Created with Sketch. 356.48KB
ACW Notification of buy-back - ACW
20/03/24 download Created with Sketch. 12.67KB
ACW Actinogen corporate presentation March 2024
20/03/24 download Created with Sketch. 3.22MB
ACW Application for quotation of securities - ACW
07/03/24 download Created with Sketch. 15.49KB
ACW ACW XanaCIDD depression trial enters final enrolment phase
07/03/24 download Created with Sketch. 241.33KB
ACW Actinogen CMO presents at ADPD 2024 conference
06/03/24 download Created with Sketch. 474.43KB
ACW Actinogen HY2024 financial results two key phase 2 trial
26/02/24PRICE SENSITIVE download Created with Sketch. 256.58KB
ACW Actinogen HY2024 financial report and Appendix 4D
26/02/24PRICE SENSITIVE download Created with Sketch. 2.75MB
ACW Application for quotation of securities - ACW
21/02/24 download Created with Sketch. 17.95KB
ACW Response to ASX Aware Query
20/02/24PRICE SENSITIVE download Created with Sketch. 934.62KB
ACW Application for quotation of securities - ACW
16/02/24 download Created with Sketch. 17.94KB
ACW Actinogen awarded UK Innovation Passport for Xanamem
15/02/24PRICE SENSITIVE download Created with Sketch. 242.2KB
ACW Application for quotation of securities - ACW
09/02/24 download Created with Sketch. 17.51KB
ACW Notification of cessation of securities - ACW
01/02/24 download Created with Sketch. 21.59KB
ACW ACW December 2023 quarterly activity report & Appendix 4C
30/01/24PRICE SENSITIVE download Created with Sketch. 510KB
ACW Positive Xanamem brain PET study peer-reviewed publication
24/01/24 download Created with Sketch. 274.99KB
ACW ACW CEO & CMO present at Sachs Neuroscience Innovation Forum
08/01/24 download Created with Sketch. 1.97MB
ACW First site activated in ACW XanaMIA Phase 2b AD trial
20/12/23 download Created with Sketch. 241.49KB
ACW Notification of cessation of securities - ACW
13/12/23 download Created with Sketch. 21.6KB
ACW Appendix 3Ys x 5
01/12/23 download Created with Sketch. 284.49KB
ACW Application for quotation of securities - ACW
01/12/23 download Created with Sketch. 30.38KB
ACW Appendix 3Y-Dr George Morstyn
28/11/23 download Created with Sketch. 194.64KB
ACW Appendix 3Y-Dr Geoff Brooke
28/11/23 download Created with Sketch. 194.89KB
ACW Notification of cessation of securities - ACW
28/11/23 download Created with Sketch. 21.61KB
ACW Actinogen receives $4.8 million R&D tax incentive rebate
28/11/23PRICE SENSITIVE download Created with Sketch. 224.74KB
ACW ACW XanaCIDD trial enrolment exceeds 50 percent
28/11/23 download Created with Sketch. 221.05KB
ACW Amended Constitution
17/11/23 download Created with Sketch. 420.34KB
ACW Results of AGM
17/11/23 download Created with Sketch. 237.83KB
ACW Actinogen 2023 AGM - Chairs address and CEOs presentation
17/11/23 download Created with Sketch. 2.48MB
ACW ACW CEO presents at Bell Potter Healthcare Conference 2023
15/11/23 download Created with Sketch. 3.15MB
ACW Application for quotation of securities - ACW
08/11/23 download Created with Sketch. 26.71KB
ACW Actinogen appoints William Souter as new CFO
08/11/23 download Created with Sketch. 239.79KB
ACW Amendment to Actinogen 2023 AGM resolutions 6 to 10
27/10/23 download Created with Sketch. 212.49KB
ACW ACW CMO presents academic poster at CTAD 2023 conference
25/10/23 download Created with Sketch. 592.86KB
ACW ACW CEO presentation for meetings at BIO Investor Forum USA
18/10/23 download Created with Sketch. 3.33MB
ACW Actinogen September quarterly activity report & Appendix 4C
16/10/23PRICE SENSITIVE download Created with Sketch. 511.35KB
ACW Annual Report to Shareholders
13/10/23 download Created with Sketch. 4.19MB
ACW Letter to Shareholders, Notice of AGM & Proxy Form
13/10/23 download Created with Sketch. 714.25KB
ACW Notification of cessation of securities - ACW
11/10/23 download Created with Sketch. 21.52KB
ACW ACW CEO presents to Dementia Trials Australia conference
06/10/23 download Created with Sketch. 1.69MB
ACW ACW presents to the Asian Society Against Dementia congress
29/09/23 download Created with Sketch. 1.54MB
ACW Change in substantial holding
27/09/23 download Created with Sketch. 166.64KB
ACW Notification of buy-back - ACW
27/09/23 download Created with Sketch. 21.78KB
ACW Date of AGM and Closing Date for Director Nominations
27/09/23 download Created with Sketch. 174.05KB
ACW Actinogen enhances XanaMIA Phase 2b Alzheimers trial
26/09/23PRICE SENSITIVE download Created with Sketch. 219.7KB
ACW Change in substantial holding
20/09/23 download Created with Sketch. 166.67KB
ACW Notification regarding unquoted securities - ACW
15/09/23 download Created with Sketch. 27.49KB
ACW Application for quotation of securities - ACW
15/09/23 download Created with Sketch. 24.81KB
ACW Appendix 3Y-Mr Malcolm McComas
12/09/23 download Created with Sketch. 195.82KB
ACW Appendix 3Y-Dr George Morstyn
12/09/23 download Created with Sketch. 195.15KB
ACW Appendix 3Y-Dr Steven Gourlay
12/09/23 download Created with Sketch. 194.14KB
ACW Appendix 3Y-Dr Geoffrey Brooke
12/09/23 download Created with Sketch. 241.05KB
ACW Notification regarding unquoted securities - ACW
11/09/23 download Created with Sketch. 23.88KB
ACW Application for quotation of securities - ACW
11/09/23 download Created with Sketch. 24.91KB
ACW Actinogen closes successful $10 million rights issue offer
07/09/23PRICE SENSITIVE download Created with Sketch. 218.02KB
(20min delay)
Last
2.4¢
Change
0.000(0.00%)
Mkt cap ! $65.08M
Open High Low Value Volume
2.4¢ 2.5¢ 2.1¢ $526.7K 22.84M

Buyers (Bids)

No. Vol. Price($)
5 431842 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 499979 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
2.4¢
  Change
0.000 ( 1.69 %)
Open High Low Volume
2.4¢ 2.5¢ 2.1¢ 9368279
Last updated 15.59pm 23/08/2024 ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.